2024-12576. Bulk Manufacturer of Controlled Substances Application: Veranova, L.P.  

  • Start Preamble

    AGENCY:

    Drug Enforcement Administration, Justice.

    ACTION:

    Notice of application.

    SUMMARY:

    Veranova, L.P., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

    DATES:

    Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before August 6, 2024. Such persons may also file a written request for a hearing on the application on or before August 6, 2024.

    ADDRESSES:

    The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.

    End Preamble Start Supplemental Information Start Printed Page 48691

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 1301.33(a), this is notice that on May 9, 2024, Veranova, L.P., 25 Patton Road, Pharmaceutical Service, Devens, Massachusetts 01434-3803, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s):

    Controlled substanceDrug codeSchedule
    Amphetamine1100II
    Methylphenidate1724II
    Nabilone7379II
    Hydrocodone9193II
    Levorphanol9220II
    Thebaine9333II
    Alfentanil9737II
    Remifentanil9739II
    Sufentanil9740II

    The company plans to bulk manufacture the listed controlled substances in order to support the manufacturing and analytical testing activities at its other Drug Enforcement Administration-registered manufacturing facility. No other activities for these drug codes are authorized for this registration.

    Start Signature

    Matthew J. Strait,

    Acting Deputy Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2024-12576 Filed 6-6-24; 8:45 am]

    BILLING CODE 4410-09-P

Document Information

Published:
06/07/2024
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2024-12576
Dates:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before August 6, 2024. Such persons may also file a written request for a hearing on the application on or before August 6, 2024.
Pages:
48690-48691 (2 pages)
Docket Numbers:
Docket No. DEA-1384
PDF File:
2024-12576.pdf